[ad_1]
in the world and Turkey, the report said that the introduction of disease treatment completion, 'the lack of treatment eradicate the disease alone is not enough, bureaucratic and the removing all physical barriers to access to treatment, people will have a very significant positive result in terms of health, "he said.
The Health Institute of the University of Barcelona, the Turkish Liver Research Association (TKAD) and Viral (19659002) noted that about 6,320 deaths related to the liver, 4,400 cases of liver cancer and 4,060 cases of decompensated cirrhosis could be avoided in this setting. Hepatitis Association for Prevention (VHSD) under the leadership of Gilead Sciences with the support of prepared with the contribution of medical specialists representing all regions of Turkey, "Turkey Hepatitis C Elimination Roadmap Report" on July 27 was announced at a press conference held in Istanbul. world
"These are briefly a 90% decrease in new hepatitis, 90% of hepatitis C is diagnosed, and at least some of these patients are diagnosed with hepatitis C," recalled Dr. World Health Organization (WHO). 80% of "We expect each country to have its own path and contribute to the objectives of WHO." In the world and in Turkey, the report says that it is very important treatment of this disease, "the lack of treatment is not enough only, the removal of bureaucracy and all the physical barriers to it." access to these treatments People will have very positive results in terms of health, "he said.
World Hepatitis Professor at the Global Institute of Health of the University of Barcelona. Dr. Jeffrey Lazarus gave a speech as a special guest and a panel was subsequently organized. Panele TKAD Chairman of the Board of Directors Dr. Ramadan Idilman, Chairman of the VHSD Division of the Board of Directors Dr. Fehmi Tabak, Vice Chairman of the Board of Directors of VHSD Prof. Dr. Rahmet Güner and Member of the Board of Directors of the Asia-Pacific Liver Research Association Dr. Necati Örmeci participated as a lecturer
Prof. Dr. Jeffrey V. Lazarus, this report states that Turkey's roadmap "Things legal arrangements with countries that Turkey can be an example for quickly reaching the goal of WHO," was -he says. Professor Dr. The world at workshops organized by Lazarus preparation process reports that emerged how the idea of the elimination of HCV, the WHO proposed goals for the elimination of the HCV, in other countries in the micro-elimination approach and benefits, and the elimination of HCV explaining with examples of best practices made so far, is essentially to be done in Turkey [19659002] VULNERABLE DISEASES NOT CONTROLLED IN THE PUBLIC CONTINUITY
Speaking at a meeting explaining the report, the president of the Viral Hepatitis War Society, Prof. Dr. Fehmi Tabak said, "There are some very important treatments, but treatment alone is not enough. With all the bureaucratic and physical barriers to accessing these treatments, very important positive results will be achieved in public health. It is also important to diagnose and disseminate issues such as access will also Turkey to achieve the goal of WHO, "he said. He emphasized that contagious diseases will continue to spread as long as they are not controlled in society. Dr. Fehmi Tabak continued his words as follows:
"We have just tried to evaluate what needs to be done in the report that was released today by Dr. Homie Razavi of United States and our colleague Prof. Dr. Lazarus Turkey due to the regulations to be carried out in accordance with the objectives of the WHO until 2030, about 4,400 cases of liver cancer, 6,320 liver can be avoided deaths induced and 4060 decompensated cirrhosis.prevent these cases and public health is very useful in terms of the effective use of both sources, so to achieve the purpose of the WHO we care too. "
If follow the advice on the report, hepatitis C POSSIBLE ELIMINATION
President of the Association of Liver Research Professor Turkey Dr.
"Since viral hepatitis was a major health problem for our country, a national program was needed for the In collaboration with TKAD and HSBC, under the direction of the Directorate General of Public Health of the Ministry of Health,
However, since the beginning of the year 2017, the workshops "Elimination of the Hepatitis C "have been organized with Gilead Sciences since early 2017. In addition, done. to date, four wide participation in making meetings, suggestions from experienced leaders in Turkey about this idea and created a report based on contributions. the recommendations contained in the report, accompanied by the elimination of hepatitis C issue in our country
THE HEPATITIS C CAN NOT BE CLEANABLE
Member of the Board of Directors of the Asia-Pacific Liver Research Association. Dr. Necati Örmeci pointed out that awareness of hepatitis C treatment not only at the public level but also at the level of doctors and the public is very low. Professor Dr. Necati Örmeci said: "Many doctors are unaware that hepatitis C can be completely eliminated from the bloodstream, especially if doctors are trained and sensitized to doctors such as family doctors, internal doctors, nurses, surgeons, anesthesiologists, psychiatrists and nephrologists.
BIOPSY OF THE LIVER IS NOT NECESSARY FOR TREATMENT
Vice President of the Viral Hepatitis War Society, Professor. Dr. Rahmet Güner also pointed out that "1970 and premature births with liver disease, intravenous drug users, prisoners, patients with a history of transplantation, dialysis treatment, HIV and those infected by hepatitis B The evaluation of HCV during pregnancy can be included in the routine program of pregnancy monitoring and access to hepatitis C treatments can be practiced in 39 countries and 58 hospitals in our country. It is therefore important that treatment be available in all provinces. "
the biopsy should be removed, indicating that Prof. Dr.
" In this way, faster and more convenient access can be obtained. "Physicians should be able to make their own choice of patients. direct antiviral agents that respond to optimal treatment for the treatment of hepatitis C. "
"
MUCH SURVIVAL IN THE COUNTRY
Gilead Sciences Executive Director, Şebnem Girgin, said at a meeting that "Gilead Sciences is the most trusted source of information in the world. We are proud to be able to contribute to the emergence of today 's report by supporting the established scientific platform and continuing our experience in other countries.
Sebnem Girgin continued his words as follows:
"As Gilead Sciences in this context, it is important that our state, our country, I would like to declare here that we have completed all our investment preparations for the national production of our products against hepatitis and that we are ready to go. "
[ad_2]
Source link
